Volum lichid pleural


 Formula Balik

Volum lichid pleural (ml) = Distanta masurata ecografic (mm) x 20


pH lichid pleural < 7.2 = infectie

The fluid is considered an exudate if any of the following are found and a transudate if all are absent (Light’s criteria) –ratio of pleural fluid to serum protein > 0.5, ratio of pleural fluid to serum LDH > 0.6, pleural fluid LDH > two thirds of the upper limits of normal serum value. Pleural fluid cholesterol > 55 mg/dL (1.42mmol/L)may also be a useful in distinguishing an exudate from a transudate.


Pulmonary Arterial Hypertension / Pulmonary Venous Hypertension


Parametru PAH Pulmonary Arterial Hypertension PVH Pulmonary Venous Hypertension
RV ↑ ±↑
LA ↓ ↑
RA/LA
Size ratio
↑ N ( LA > RA)
Sept interatrial Impins spre stanga Impins spre stanga
RVOT  Frecvent Rar
E/A < 1 >1
Lat e' N ↓
Lat E/e' < 8 > 10
Ao pressure N / ↓ N / ↑
PCWP ⋜ 15 mmHg > 15 mmHg
PADP - PCWP > 7 mmHg < 5 mmHg

Rocuronium - blocare neuromusculara si reversie


 Administrarea de rocuroniu

- doza de IOT calculata la IBW

0.6 mg/kg IBW (doza se scade cu 15 % pentru femei)

Monitorizare EMG

- TOF count sau PTC

- evitare administrare in ultimele 30 min ale procedurii daca este posibil

Reversie

  • TOF Ratio ≥ 0.4 dar < 0.9

Neostigmina 15-30 𝜇g/kg + Glicopirolat 1:5 imediat dupa neostigmina

  • TOF Ratio < 0.4

Sugammadex 2 mg/kg

  • TOF Ratio ≥ 0.9

NU este nevoie de reversie

  • TOF Count = 0 (PTC ≥ 1)

Sugammadex 4 mg/kg


Daca TOF ratio < 0.9 dupa reversie initiala se adminsitreaza Sugammadex

- dupa 3 minute daca reversia initiala a fost cu Sugammadex

- dupa 10 minute daca reversia initiala a fost cu Neostigmina


Antitrombotice

Antiagregante plachetare

  • Analogi de prostaglandina PGI2
    • Beraprost
    • Iloprost
    • Prostaciclina (Epoprostenol)
    • Treprostinil

  • Inhibitori ai glicoproteinei IIb/IIIa
    • Abciximab
    • Eptifibatida
    • Tirofiban

  • Inhibitori ai receptorului P2Y12
    • Tienopiridine
      • Clopidogrel  
      • Prasugrel  
      • Ticlopidina 
    • Analogi nucleotidici/nucleozidici
      • Cangrelor  
      • Elinogrel  
      • Ticagrelor

  • Inhibitori ai ciclooxigenazei
    • Acid acetilsalicilic/Aspirina  
    • Aloxiprina  
    • Carbasalat calcic  
    • Indobufen  
    • Triflusal

  • Altele
    • Dipiridamol  
    • Ditazol  
    • Cilostazol  - inhibitor de fosfodiesteraza
    • Vorapaxar - antagonist protease-activated receptor-1 

Anticoagulante

  • AntagoniČ™ti ai vitaminei K
    • Cumarine: 
      • Acenocumarol  
      • Biscumacetat de etil  
      • Dicumarol  
      • Fenprocumona  
      • Warfarina
    • 1,3-indandione: 
      • Clorindiona  
      • Difenadiona  
      • Fenindiona
  • Inhibitori ai factorului Xa
    • Heparina
    • Heparina cu greutate moleculara mica
      • Certoparina  
      • Dalteparina  
      • Enoxaparina - Clexane  
      • Nadroparina  
      • Reviparina  
      • Tinzaparina
    • Oligozaharide 
      • Fondaparinux  
      • Idraparinux
    • Heparinoizi
      • Danaparoid  
      • Dermatan sulfat  
      • Sulodexid
    • Inhibitori direcČ›i Xa: 
      • Apixaban  
      • Betrixaban  
      • Edoxaban  
      • Rivaroxaban
  • Inhibitori direcČ›i de trombina (IIa)
    • BivalenČ›i
      • Hirudina  
      • Bivalirudina  
      • Desirudina  
      • Lepirudina
    • UnivalenČ›i
      • Argatroban  
      • Dabigatran  
      • Efegatran  
      • Inogatran  
      • Melagatran  
      • Ximelagatran
  • Altele
    • Antitrombina

Trombolitice/fibrinolitice

  • Activatori de plasminogen: 
    • Alteplaza  
    • Reteplaza  
    • Tenecteplaza  
    • Desmoteplaza  
    • Urokinaza  
    • Anistreplaza  
    • Monteplaza  
    • Streptokinaza
  • Altele
    • Ancrod  
    • Brinaza  
    • Fibrinolizina


Hidroxicobalamina


Mecanism:

- scavenging nitric oxide

- scade vasodilatatia

- catecholamine-sparing effect - scade necesarul de catelcolamine


Indicatii:

- intoxicatia cu cianuri

- hipotensiune refractara la administrarea de catecolamine

- efect antioxidant si mitocondrial

- socul vasoplegic post chirurgie cardiaca


Administrare:

- bolus 5 - 10 g in15 minute

Se poate repeta


Efecte secundare:

- colorare rosie a pielii, urinii si plasmei (temporar si fara alte efecte)

- hipertensiune (datorita vasoconstrictiei)

- interfera cu teste de laborator: HLG, creatinina, coagulare, lactat, bilirubina